Skip to content

Effect of Local Application of Boron on Diabetic Foot Ulcers

Prospective Randomized Study of Local Application of Boron on Diabetic Foot Ulcers: Effect of Healing Process

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02087215
Enrollment
100
Registered
2014-03-14
Start date
2014-01-31
Completion date
2015-03-31
Last updated
2014-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot Ulcer

Keywords

diabetes mellitus, foot ulcer, boron, wound care

Brief summary

Boron as a naturally occurring element has some metabolic and inflammatory actions. The antibacterial activity against gram negative bacteria is also known. Boron deficiency is shown to be related with impaired wound bone healing in rats. Therefore, special wound care formulas containing boron may have some positive effect on wound healing of the patients with diabetic foot ulcers.

Detailed description

Local treatment of diabetic foot ulcers: 1. Classification of International Working Group of the Diabetic Foot (IWGDF) 2. pre-treatment measurements including diameter and area 3. pre-treatment laboratory values including fasting glucose, hemoglobin, hemoglobin A1c, leucocyte count and c-reactive protein 4. pre-treatment wound culture 5. treatment either by placebo gel containing polymer of carbopol ultrex (1%) or by formulation gel: addition of borate as sodium penta boric acid pentahydrate 3% (w/v) and two different copolymer as pluronic block namely F68 2% (w/v) and f127 2% (w/v). 6. post-treatment measurements and values

Interventions

DRUGboron gel

application of a formulation gel: addition of borate as sodium penta boric acid pentahydrate 3% (w/v) and two different copolymer as pluronic block namely F68 2% (w/v) and f127 2% (w/v) to diabetic foot ulcers.

DRUGPlacebo

Sponsors

Bezmialem Vakif University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* diabetic food ulcer classified byInternational Working Group of the Diabetic Foot (IWGDF) as grade 1 and 2

Exclusion criteria

* previous vascular surgery on the side that the ulcer is present * uncontrolled diabetes mellitus * presence of osteitis, abscess, osteomyelitis, gangrene on the side that the ulcer is present * diabetic food ulcer classified byInternational Working Group of the Diabetic Foot (IWGDF) as grade 3

Design outcomes

Primary

MeasureTime frameDescription
number of the participants with complete epithelization of diabetic foot ulcerup to 4 weekshealing and complete epithelization of diabetic foot ulcer with regard to time in weeks; comparison with progression or regression of grades of the wound based on classification sytems of International Working Group of the Diabetic Foot (IWGDF) and area of the wound measured as square centimeter.

Secondary

MeasureTime frameDescription
number of participants in whom local infective complications develop in diabetic foot ulcer patientsup to 4 weeksdevelopment of local infective complications including osteitis, abscess, osteomyelitis and gangrene

Other

MeasureTime frameDescription
improvement of inflammatory parameters in diabetic foot ulcersup to 4 weeksimprovement of inflammatory parameters in diabetic foot ulcers including leukocyte count, c-reactive protein and wound culture

Countries

Turkey (Türkiye)

Contacts

Primary Contactmustafa hasbahceci, md
hasbahceci@yahoo.com+902124531700

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026